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Abstract
Tracing the evolution of ancient diseases depends on the availability and accessibility of suitable biomarkers in
archaeological specimens. DNA is potentially information-rich but it depends on a favourable environment for preservation.
In the case of the major mycobacterial pathogens, Mycobacterium tuberculosis and Mycobacterium leprae, robust lipid
biomarkers are established as alternatives or complements to DNA analyses. A DNA report, a decade ago, suggested that a
17,000-year-old skeleton of extinct Bison antiquus, from Natural Trap Cave, Wyoming, was the oldest known case of
tuberculosis. In the current study, key mycobacterial lipid virulence factor biomarkers were detected in the same two
samples from this bison. Fluorescence high-performance liquid chromatography (HPLC) indicated the presence of mycolic
acids of the mycobacterial type, but they were degraded and could not be precisely correlated with tuberculosis. However,
pristine profiles of C29, C30 and C32 mycocerosates and C27 mycolipenates, typical of the Mycobacterium tuberculosis
complex, were recorded by negative ion chemical ionization gas chromatography mass spectrometry of pentafluorobenzyl
ester derivatives. These findings were supported by the detection of C34 and C36 phthiocerols, which are usually esterified to
the mycocerosates. The existence of Pleistocene tuberculosis in the Americas is confirmed and there are many even older
animal bones with well-characterised tuberculous lesions similar to those on the analysed sample. In the absence of any
evidence of tuberculosis in human skeletons older than 9,000 years BP, the hypothesis that this disease evolved as a
zoonosis, before transfer to humans, is given detailed consideration and discussion.
Citation: Lee OY-C, Wu HHT, Donoghue HD, Spigelmal M, Greenblatt CL, et al. (2012) Mycobacterium tuberculosis Complex Lipid Virulence Factors Preserved in
the 17,000-Year-Old Skeleton of an Extinct Bison, Bison antiquus. PLoS ONE 7(7): e41923. doi:10.1371/journal.pone.0041923
Editor: Petros C. Karakousis, Johns Hopkins University School of Medicine, United States of America
Received April 24, 2012; Accepted June 29, 2012; Published July 30, 2012
Copyright:  2012 Lee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by Leverhulme Trust Project Grant F/00 094/BL (GSB, DEM, OY-CL) and Wellcome Trust Grant 080988/Z/06/Z (GSB, OY-CL). A
grant from the UK Natural and Environmental Research Council (DEM, GSB) provided access to the Mass Spectrometry Unit at the University of Bristol, UK. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: g.besra@bham.ac.uk
Introduction
Tuberculosis was present from an early date in North America,
but clear evidence for its distribution and origins is by no means
complete [1,2]. An intriguing aspect of ancient North American
tuberculosis is its apparent prevalence in ice-age bovids and
mastodons who may have nurtured the disease without being
rapidly killed [3,4]. Bone pathology of skeletons, collected in
Natural Trap Cave (Wyoming), indicates the presence of such an
ancient animal tuberculosis reservoir [5,6]. Lesions suggestive of
tuberculosis were seen in skeletons of bighorn sheep, musk ox and
Bison antiquus [6]. In this bison, dated to 17,8706230 BP, it was
possible to demonstrate ancient DNA characteristic of the
Mycobacterium tuberculosis complex, confirming the oldest proven
case of tuberculosis [7].
The use of DNA can be complemented by other biomarkers, as
reviewed recently [8,9]. Mycolic acids (MAs) (Figure 1A) and
phthiocerol dimycocerosate (PDIM) waxes (Figure 1B, C) are
characteristic major components of the cell envelopes of M.
tuberculosis [10,11]. Using a combination of DNA and MA analysis,
the oldest case of human tuberculosis infection was established in
skeletons of a woman and adjacent child from Atlit-Yam (Israel)
[12]. Analysis of the mycocerosate components (Figure 1B) of
PDIM waxes was established in the investigation of a skeletal
collection from Coimbra (Portugal) [13]. In the same study [13],
another lipid biomarker, C27 mycolipenic acid (Figure 1B), was
encountered in a minority of samples.
The present study investigated the same bone samples used
previously [7], and recorded a weak mycolic acid profile.
However, a clear profile of mycocerosic acids was obtained,
supported by the identification of phthiocerol components. In
addition, a strong presence of mycolipenic acids was recorded.
These findings independently document the presence of tuber-
culosis in this ancient extinct bison skeleton and demonstrate the
long-term stability of these lipid virulence factors. The confir-
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Figure 1. Lipid biomarkers for M. tuberculosis. A. Generalized structures of the a-, methoxy- and ketomycolates; the main components are in
brackets. B. Structures of mycolipenate and mycocerosates, showing ions used for selected ion monitoring on NI-CI GC-MS analysis. C. Structures of
members of the phthiocerol family.
doi:10.1371/journal.pone.0041923.g001
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mation of tuberculosis in an animal bone much older than any
positive human skeletons raises the possibility that the ancient
evolution of the disease was as a zoonosis.
Results and Discussion
Bone Samples and Extraction of Lipids
The two bone samples analysed were from an extinct bison
(Bison antiquus) buried in sediments, dated to 17,8706230 years BP,
in Natural Trap Cave (Wyoming) [7]. The first sample (‘‘Bison 1’’)
originated from the undermined articular surface of a metacarpal
but the second sample (‘‘Bison 2’’) was from a site on the same
bone remote from this lesion [7]. The material was exactly the
same as that used for the previous ancient tuberculosis DNA
analyses [7].
Bone samples were hydrolysed by a protocol designed to release
all the long-chain lipid components [9,12,13] and the acidic
components were converted to pentafluorobenzyl (PFB) esters
[12,13]. The extract was fractionated into three distinct lipid
Figure 2. Fluorescence HPLC of pyrenebutyric acid derivatives
of pentafluorobenzyl esters of total mycolic acids. The
derivatives analysed were from Bison 1 and Bison 2 bones and standard
M. tuberculosis. A. Reverse phase HPLC of total mycolates. B. Normal
phase HPLC of total mycolates collected from reverse phase
separations.
doi:10.1371/journal.pone.0041923.g002
Figure 3. Reverse phase fluorescence HPLC of pyrenebutyric
acid derivatives of pentafluorobenzyl esters of mycolic acid
classes. The derivatives analysed were from Bison 1 and Bison 2 bones
and standard M. tuberculosis. The analyzed fractions were collected
from the normal phase separation (Figure 2B). A. a-Mycolates. B.
Methoxymycolates. C. Ketomycolates.
doi:10.1371/journal.pone.0041923.g003
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classes, containing non-hydroxylated fatty acid PFB esters, mycolic
acid PFB esters and underivatised phthiocerols [12,13]. The latter
two classes were allowed to react with pyrenebutyric acid (PBA) to
produce PBA-PFB mycolates and di-PBA derivatives of the
phthiocerol family (Figure 1). These fluorescent derivatives were
analysed by sequential combinations of reverse and normal phase
high performance liquid chromatography (HPLC) [12]. The non-
hydroxylated fatty acid PFB esters were fractionated further to
produce material enriched in PFB esters of mycocerosic and
mycolipenic acids, which were analysed by negative ion chemical
ionization gas chromatography mass spectrometry (NICI-GCMS)
and selected ion monitoring (SIM) [13].
Detection of Mycolic Acids
Reverse phase HPLC of the PBA-PFB mycolate fractions
indicated the presence of long-chain mycolates in sample Bison 1,
but the profile for Bison 2 was very weak (Figure 2A). The total
components in the region corresponding to mycolates, from the
reverse phase HPLC of Bison 1 and 2 extracts, were collected and
analysed by normal phase HPLC (Figure 2B). A recognizable profile
was recorded for Bison 1, with the a-mycolates being the most
abundant. However, the signal was not clean, with minor additional
peaks eluting before and after the main component (Figure 2B).
Methoxymycolates were apparently present in low amounts, but
there was only a weak indication for ketomycolates. In the normal
phase HPLC profile of the total mycolates from Bison 2 no clear
peaks could be discerned. The fractions, corresponding to the
positions of a-mycolates, methoxymycolates and ketomycolates
(Figure 2B), were collected and re-analyzed by reverse phase HPLC
(Figure 3). An informative profile was obtained for the a-mycolates
from Bison 1 but nothing was observed for Bison 2 (Figure 3A). Weak
indications of methoxymycolates and ketomycolates were only
discernible in Bison 1 (Figure 3B, C).
Detection of Mycocerosic and Mycolipenic Acids
Positive profiles of C29, C30 and C32 mycocerosates were
recorded by SIM NICI-GCMS for both Bison 1 and 2 (Figure 4).
Additionally, lesser proportions of C27 mycocerosates were
distinguishable, but no significant proportions of C33 and C34
mycocerosates were encountered (Figure S1). The mycocerosates
were observed as characteristic double peaks, due to partial
racemization during the alkaline hydrolysis [13]. Positive recog-
nition of the M. tuberculosis complex mycocerosate pattern was
confirmed by the GC retention time values, particularly the
overlapping of the C29 and C30 components (Figure 4). This highly
diagnostic chromatographic behaviour is a result of the tetra-
methyl-branched C30 mycocerosate being relatively more volatile
in comparison with the trimethyl-branched C29 ester [9,13]. In
both Bison 1 and 2, a substantial proportion of C27 mycolipenate
was observed (Figure 4) as a single peak, racemization not being
possible [9,13]. The identification of C27 mycolipenate was also
confirmed by comparison of the GC retention time with an
authentic standard (Figure 4) and correlation with a previous
detailed study [13]. The full range of positive and negative NICI-
Figure 4. Selected ion monitoring NI-CI GC-MS of mycolipenic
and mycocerosic acid pentafluorobenzyl fractions. A. Bison 1. B.
Bison 2. C. Standard M. tuberculosis. The m/z 407 (mycolipenate), 409,
437, 451 and 479 (mycocerosates) ions correspond to the components
shown in Figure 1B. The intensities of the mycocerosate and
mycolipenate peaks, in square brackets, are normalized to that [100]
of the major C32 mycocerosate. It was not possible to record all three
profiles on the same occasion, so the retention times for the standard
M. tuberculosis extract do not correspond exactly. In profiles A and B,
the C27 m/z 409 peaks at 21.81 and 21.80, respectively, correspond to
straight-chain heptacosanoate.
doi:10.1371/journal.pone.0041923.g004
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GCMS mycocerosate and mycolipenate profiles is shown in
Figure S1.
Detection of Phthiocerol Family
Reverse phase HPLC of the PBA phthiocerol fraction from
Bison 1 and 2 both showed components corresponding to C34 and
C36 phthiocerol A and C35 phthiodiolone (Figure 5A). The
collected total PBA phthiocerol family fractions were analyzed by
normal phase HPLC (Figure 5B), providing profiles with
components corresponding to phthiocerols A and B and
phthiodiolone. The separated fractions from the normal phase
analysis (Figure 5B) were subjected to reverse phase HPLC, but
there was insufficient material for profiles to be registered.
Significance of the Presence of Lipid Biomarkers
The presence of mycolic acids, having an overall size similar to
those found in M. tuberculosis (Figure 2A), is highly significant,
providing confirmation of the previous recovery of DNA
characteristic of the M. tuberculosis complex [7]. In that study [7],
spoligotyping indicated that the infection was not due to M. bovis,
but M. tuberculosis or M. africanum were possibilities. Not
surprisingly, the bone sample taken from near the observed lesion
(Bison 1) gave the best profile, but there was a very faint response
for Bison 2 (Figure 2A). The normal phase HPLC examination of
the collected mycolates (Figure 2B) gave confirmatory evidence for
a-mycolates in Bison 1, with one good sharp peak accompanied by
some possibly degraded components (Figure 2B). The Bison 1
extract also had a broad peak, possibly representing methoxymy-
colates, and a slight elevation of the baseline might be interpreted
as a suggestion of ketomycolates (Figure 2B). If diagenetic
modification of mycolates takes place, it is probable that the more
hydrophilic and chemically reactive ketomycolates are more
susceptible, followed by the intermediate methoxymycolates and
the relatively hydrophobic a-mycolates. For Bison 2, the normal
phase HPLC analysis of total mycolates was negative (Figure 2B).
On subjecting total a-mycolates, collected from the normal phase
HPLC analyses (Figure 2B), to reverse phase HPLC an acceptable
profile was recorded for Bison 1 (Figure 3A). This profile
(Figure 3A) corresponds to the standard, but the peaks are
broadened by possible degradation. It is also encouraging that a
very weak series of peaks can be discerned for methoxymycolates
and ketomycolates in Bison 1 (Figure 3B, C). The above evidence
points to the presence of mycobacterial mycolic acids, but a clear
diagnosis of M. tuberculosis complex infection cannot be made solely
on these data.
Of greater significance is the discovery of pristine C29, C30 and
C32 mycocerosates and C27 mycolipenate (Figure 4) and the C34
and C36 phthiocerols A (Figure 5). This combination of
mycocerosates is typical of M. tuberculosis sensu stricto [11,13], as is
the presence of comparable amounts of the C34 and C36
phthiocerols. A limited study [14] indicated that M. bovis usually
has an enhanced proportion of C27 mycocerosate and a
preponderance of C34 over C36 phthiocerols, when compared
with M. tuberculosis sensu stricto. It is interesting that the proportion
of phthiodiolone in Bison 1 is comparable to that of phthiocerol A.
For Bison 2, however, phthiodiolone is reduced in proportion; this
indicates that this ‘‘keto’’ component may have experienced some
selective degradation as for ketomycolates (Figure 2B). The normal
phase HPLC peaks (Figure 5B) for phthiocerol A appeared to be
doublets, suggesting some diagenetic racemization. The presence
of both mycocerosates and phthiocerols in the same extract
suggests that intact PDIM waxes were present in these ancient
bones. These PDIM waxes are particularly robust, surviving acid
methanolysis and aqueous alkaline hydrolysis [14,15]. It is not
surprising, therefore, that they are apparently recovered intact
from such an ancient source, when mycolic acids are diminished in
abundance (Figures 2, 3, 4, 5). If PDIMs can survive intact for
,17,000 years, it appears possible that, in favourable circum-
stances, they might be found in archaeological material way back
into antiquity.
It is more surprising, however, that clear evidence for
mycolipenic acid was observed in both samples. Mycolipenic acid
[11,13] is a constituent of characteristic glycolipids [16], the penta-
acyl trehaloses (PATs) [16,17]. Mycolipenates appear to be limited
in distribution to virulent strains of members of the M. tuberculosis
complex, such as M. tuberculosis, M. bovis and M. africanum [17]. It
might be expected that the trehalose unit would render PATs
susceptible to degradation compared to the non-polar PDIM
Figure 5. Fluorescence HPLC of di-pyrenebutyric acid deriva-
tives of members of the phthiocerol family. The derivatives
analysed were from Bison 1 and Bison 2 bones and standard M.
tuberculosis. A. Reverse phase HPLC of total phthiocerol family fraction.
B. Normal phase HPLC of phthiocerol family derivatives collected from
reverse phase separations. Abbreviations: PA, phthiocerol A; PB,
phthiocerol B; PO, phthiodiolone.
doi:10.1371/journal.pone.0041923.g005
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waxes. However, the PATs are also relatively non-polar [16] and
hydrophobic, due to the presence of long-chain fatty acid
substituents on five out of the eight trehalose sites [17].
Mycolipenates may survive in this protected hydrophobic envi-
ronment, although there is currently no evidence for the survival of
intact PAT glycolipids. Another possibility is that the conjugated
ab-unsaturated unit in the mycolipenate [Figure 1B] confers
additional resistance to diagenesis.
M. tuberculosis produces a class of relatively polar diacylated
trehalose (DAT) glycolipids, with mycolipanolic and mycosanoic
(2,4-dimethyldocosanoic) acid components [11,16,18]. Mycolipa-
nolate was not investigated, but no evidence was obtained by
NICI-GCMS for an ion at m/z 367, corresponding to C24
mycosanoate (Figure S1). It appears, therefore, that mycolipenic
acid (Figure 1B) is an informative biomarker for ancient
tuberculosis. Mycolipenate was found in low abundance in only
9 out of 37 mycocerosate-positive skeletons from the more-recent
Coimbra collection [13]. Mycolipenates also have value in
distinguishing ancient tuberculosis and leprosy, as they are not
synthesized by Mycobacterium leprae [11].
The previous aDNA results [7] indicated that the infection did
not correlate with bovine tuberculosis, but could be due to M.
tuberculosis or M. africanum. The present lipid results do not
contradict this conclusion. In particular, the mycocerosate profiles
are indicative of M. tuberculosis, as only small proportions of C27-
mycocerosate were recorded (Figure 4). In previous studies, it was
shown that extracts of M. bovis had relatively enhanced amounts of
this component [14]. The profiles for members of the phthiocerol
family (Figure 4) also resemble those for M. tuberculosis more closely
than those for M. bovis, with a predominance of C36 phthiocerol A
over the C34 component [14]. The degraded mycolate profiles
(Figs. 2 and 3) are not particularly informative, but the size of the
a-mycolates is compatible with those from members of the M.
tuberculosis complex. The presence of C27-mycolipenate is not
diagnostic, as this component is found in various virulent members
of the M. tuberculosis complex [17]. The overall conclusion is that
the infection was by a member of the M. tuberculosis complex, with
M. bovis being an unlikely candidate.
Looking beyond the obvious paleopathological significance of
the present results, it should be noted that, to our knowledge, these
MAs and PDIMs are the oldest recognizable virulence factors ever
recorded for tuberculosis, or perhaps any other infectious disease.
The importance in virulence of these two lipid classes can be
attributed to at least two features of these compounds. Firstly, both
the MAs and PDIMs are considered to be integral components of
the cell envelope architecture of M. tuberculosis [10,11]. In M.
tuberculosis, the intense hydrophobicity of the outer membrane may
contribute to the defences of the pathogen in resisting attack by
infected host cells. A wide range of biological activities have been
associated with the lipids identified in this study and these have
been comprehensively reviewed [19–21]. In particular, there is
evidence that both MAs and PDIMs are actively exported with a
direct influence in generating foamy macrophages and granulo-
mas, contributing to the disease process [22–25]. These exported
lipids may accumulate in bone matrices, thereby enhancing their
preservation and eventual detection. Although the virulence factor
activity of these lipids has been demonstrated for modern human
tuberculosis, it is likely that the lipids would have a similar role in
ancient animal disease.
Implications for the Evolution of Tuberculosis
Great strides are being made in the paleogenomics of
tuberculosis [26–36], particularly in unravelling the complexities
of the interrelationships between relatively modern variants
responsible for current disease [30,31]. However, the early
evolutionary pathways, defining exactly from where and how
tuberculosis originated, remain indistinct. The challenge is to chart
a pathway from ancestral environmental freely-circulating myco-
bacterial species to M. tuberculosis sensu stricto, which is an obligate
pathogen with no environmental niche. Currently favoured
hypotheses all point to an evolutionary bottle-neck, estimated to
have been around 35,000 BP [27,28,35,37]. Subsequent to this
time period, the evolution of a range of particular clades follows an
almost linear clonar evolutionary pattern, with key deletions
leading to the well-defined modern M. tuberculosis complex causing
tuberculosis in humans and various animals [26–36,38].
There is increasing evidence that, before reaching the disconti-
nuity of the bottle-neck, extensive horizontal gene transfer (HGT)
was taking place in ancestral tuberculosis strains [27,38–41]. These
pre-bottle-neck ancestral strains, sometimes termed ‘‘M. prototuber-
culosis’’ [28,42], have been associated with the ‘‘smooth’’ colony-
forming Canetti variants of M. tuberculosis [28], but ‘‘Mycobacterium
canettii’’ isolates are not necessarily considered to be living
representatives of the progenitor of the M. tuberculosis complex
[32,42,43]. ‘‘M. canettii’’ strains can be regarded as a heterogeneous
‘‘out-group’’ whose evolution is distinct from other members of the
M. tuberculosis complex [30,31,33]. ‘‘M. canettii’’ smooth strains
continue to be encountered in isolated cases of tuberculosis, but they
are usually confined to certain locations in the Horn of Africa
[43,44]. Inter human transfer is not known, but children and
expatriates are more susceptible to infection, suggesting that the
indigenous population has acquired significant immunity [44]. The
geographical restriction, genetic diversity and specialised nutritional
requirements of ‘‘M. canettii’’ isolates strongly favour an environ-
mental reservoir [44]. It is not known if these bacteria can also be
part of an animal reservoir in the Horn of Africa.
The positive identification of tuberculosis in this ancient bison
skeleton establishes a clear beacon point in the historical record
around which to explore an evolutionary scenario for tuberculosis
in North America and elsewhere. Clearly recognisable human
tuberculosis has not been recorded before 9,000 BP in Eurasia/
North Africa [12,34] and 2,100–1,900 BP in the Americas
[1,2,45]. In an interesting, but isolated, report, tuberculosis was
suggested to be a cause of possible endocranial paleopathology in a
fossilized Homo erectus skeleton, dated 500,000 BP [46]; however,
alternative interpretations have been suggested [47]. Apart from
this single unconfirmed case [46], any clear indications for the
presence of tuberculosis in very ancient human remains have not
been reported. However, in the animal kingdom there are
indications of widespread tuberculosis. In addition to the bison
metacarpal, analysed in this study, 19% of 1,002 bovid specimens
[3] and 52% of 113 mastodon bones [4] had similar lesions
indicative of tuberculosis. The age range for the bovids is 125,000
to 8,000 BP [3] and the mastodon skeletons cover a range from
38,000 to 10,000 BP [4]. Bone lesions cannot be considered as
complete proof of tuberculosis diagnosis, but the dearth of human
bones with comparable lesions over the same time period of at
least 100,000 years is very striking. This could be a consequence of
the hunter-gatherer human population being thinly spread,
whereas it may be easier to locate bones from large animal herds.
A solution of this conundrum could simply be that M. tuberculosis
was principally an animal disease during its early evolution, with
transmission to humans occurring later. It has been noted
previously [34,35,42] that such a scenario should not be dismissed.
Conclusions
The highly sensitive analytical protocols employed have
detected key tuberculosis lipid biomarkers in two samples from
Lipid Biomarkers for Pleistocene Tuberculosis
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an extinct bison, lending solid support to previous aDNA
conclusions [7]. Mycolic acids (Figure 1A) were indicated (Figs. 2
and 3), but the profiles demonstrated degradation and a positive
diagnosis of tuberculosis could not be given. This contrasts with
the very strong profiles (Figure 4) recorded for the mycocerosic
acid components (Figure 1B) of the phthiocerol dimycocerosate
(PDIM) waxes and, remarkably, for the mycolipenic acid
(Figure 1B) component of pentaacyl trehaloses (PATs). Profiles
(Figure 5) for components of the phthiocerol family (Figure 1C)
suggested that intact PDIMs may have been present.
Conclusive evidence has been provided for the presence of
tuberculosis in this ancient bison by detection of these lipid
virulence factors. It has also been confirmed that tuberculosis may
be identified in absence of macroscopically recognizable bone
lesions and defects. Analysis of ancient DNA provides the most
informative way to trace the evolution of tuberculosis, but the
developing portfolio of diagnostic lipids, illustrated here, offers
alternative routes to chart these evolutionary processes. The
confirmation of tuberculosis in this exceptionally old 17,000 BP
extinct bison and the current absence of any proven human
tuberculosis older than 9,000 BP demands exploration of a
hypothesis that tuberculosis may have originated and become
established as a widespread zoonosis. Many, many more samples
of potentially tuberculosis infected human and animal bones are
urgently needed for analysis to support or disprove this or any
other viable hypothesis.
Materials and Methods
Samples
The material, as used for the previous ancient tuberculosis DNA
analyses [7], was from an extinct bison (Bison antiquus) buried in
sediments, dated to 17,8706230 years BP, in Natural Trap Cave
(Wyoming). The first sample (‘‘Bison 1’’; 13.5 mg) originated from
the undermined articular surface of a metacarpal but the second
sample (‘‘Bison 2’’; 13.0 mg) was from a site on the same bone
remote from this lesion [7]. The metacarpal bone was stored in a
dry sterile environment to avoid any possibility of external
contamination. In the prevailing conditions of Natural Trap
Cave, the possibility of external post mortem infection with M.
tuberculosis is most unlikely. M. tuberculosis H37Rv was used to
prepare standard profiles. Stringent precautions were taken
against sample carry-over during the analyses. Essentially, this
amounted to using new disposables for every analysis and running
blanks between samples.
Lipid Extraction
Samples were hydrolysed by heating with 30% potassium
hydroxide in methanol (2 ml) and toluene (1 ml) at 100uC
overnight [12,13,48,49]. Long-chain compounds were extracted
by a modification of a published method [13], substituting
dichloromethane with toluene [48,49] to ensure efficient extrac-
tion of the phthiocerols. The extract was treated with pentafluor-
obenzyl bromide, under phase-transfer conditions [12,13,48,49],
to convert acidic components into pentafluorobenzyl (PFB) esters.
Subsequent fractionation on an Alltech 209250 (500 mg) normal
phase silica gel cartridge [12,13,48,49] gave fractions containing
non-hydroxylated PFB esters, MA PFB esters and underivatized
phthiocerols.
Mycolic Acid Analysis
The MA PFB esters were reacted with pyrenebutyric acid
(PBA) to produce PBA-PFB MA derivatives, which were
purified on an Alltech 205250 (500 mg) C18 reverse phase
cartridge [12,48,49]. The PBA-PFB mycolates were analysed by
sequential reverse and normal phase HPLC, as described
previously [12,48,49].
Mycocerosic and Mycolipenic Acid Analysis
In a simplification of a previous protocol, which involved
normal phase HPLC pre-purification [13], the non-hydroxylated
PFB ester fraction was fractionated on an Alltech 205250
(500 mg) reverse phase silica gel cartridge, using a water-
methanol/methanol/methanol-toluene elution sequence (Figure
S2). A fraction enriched in mycocerosic acid and other longer
chain (.C20) PFB esters was eluted by 100% methanol with the
more usual C12 to C20 esters eluting in the earlier water/
methanol fractions. The fraction containing possible mycocer-
osates and mycolipenates, was analysed by negative ion
chemical ionization gas chromatography mass spectrometry
(NICI-GCMS), as previously described [13] (Figure S1). PFB
esters, on NICI-GCMS, fragment to produce negative carbox-
ylate [M – H]- ions, which can be detected at high sensitivity.
Selected ion monitoring (SIM) was used to search for
mycocerosate carboxylate ions at m/z 367.6311 (C24),
395.6844 (C26), 409.7111 (C27), 437.7645 (C29), 451.7911
(C30), 479.8445 (C32), 493.8712 (C33) and 507.8978 (C34).
Additionally, m/z 407.6952 was monitored for the presence of
the C27 mycolipenate carboxylate ion. Partial racemisation of
mycocerosates during the alkaline hydrolysis leads to the
formation of diasteroisomers, which resolve on gas chromatog-
raphy to give characteristic doublets; in contrast, mycolipenates
are singlets as they cannot racemise [13].
Phthiocerol Family Analysis
In a new procedure, the phthiocerol fraction was converted to
PBA esters by reaction with pyrenebutyric acid, under the same
conditions used to derivatize MA PFB esters [12,48,49]. The crude
phthiocerol di-PBA esters were purified by an Alltech 205250
(500 mg) C18 reverse phase cartridge, utilizing combinations of
water, acetonitrile and dichloromethane; the PBA phthiocerols
eluted in 100% acetonitrile and acetonitrile/dichloromethane 54:6
and 48:12 fractions (Figure S3). Reverse phase HPLC was
performed on an Alltech 81412 Alltima C18 column (3 m,
4.6 mm650 mm) column in a VWR Hitachi Elite LaChrom
HPLC linked to an L-2480 fluorescence detector, utilizing a
gradient of acetonitrile/tetrahydrofuran, from 85:15 to 60:40 in
30 min (Figure S4). The fraction, corresponding to derivatives of
members of the phthiocerol family, was collected and analyzed by
HPLC on normal phase columns (Alltech 81414 Alltima Silica,
3 mm 5064.6 mm). Eluting with heptane/ethyl acetate 99:1 for
1 min, was followed by gradient of heptane/ethyl acetate 99:1 to
91:9 over 30 mins (Figure S4).
Supporting Information
Figure S1 Complete results of selected ion monitoring
(SIM) negative ion-chemical ionisation gas chromatog-
raphy-mass spectrometry (NICI-GCMS) analysis of
pentafluorobenzyl (PFB) ester fractions, corresponding
to mycocerosates and mycolipenates.
(DOC)
Figure S2 Solvent system for the purification of penta-
fluorobenzyl (PFB) mycocerosates on C18 reverse phase
cartridges.
(DOC)
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Figure S3 Solvent system for the purification of pyr-
enebutyric acid (PBA) derivatives of members of the
phthiocerol family on C18 reverse phase cartridges.
(DOC)
Figure S4 HPLC conditions for analysis of pyrenebu-
tyric acid (PBA) derivatives of members of the phthio-
cerol family.
(DOC)
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